reports
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Can...
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 () – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a commercial-stage precision diagnostic company, announces the introduction of a non-invasive genetic prostate cancer test through its urology sales channel. With a simple saliva sample, the new comprehensive hereditary prostate cancer test offering provides insights into a patient’s risk of developing cancer, d...
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Result...
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42%2023 gross margin expanded by 10.7 percentage points over prior yearConference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 6, 2024 () – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the fourth quarter and year ended December 31,...
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Resul...
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 Company to Host Conference Call with Live Q&A, March 6, 2024 at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 21, 2024 – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2023, after market close on Wednesday, March 6, 2...
Mdxhealth Announces Resignation of Board Member
Mdxhealth Announces Resignation of Board Member Mdxhealth Announces Resignation of Board Member IRVINE, CA, and HERSTAL, BELGIUM – February 16, 2024 () – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced that Jan Pensaert has stepped down from the Board of Directors of mdxhealth. His resignation was effective as of February 15, 2024. Mr. Pensaert’s resignation is not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company. Michael K. McGarrity,...
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenu...
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – January 8, 2024 () – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today reported preliminary fourth quarter and full year 2023 revenues and issued 2024 revenue guidance. The Company expects to report fourth quarter and full year 2023 revenues of approximately $19.4 and $70.2 million, respectively, wi...
MDxHealth Announces Completion of Transition to Single Listing on Nasd...
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq NEWS RELEASE – REGULATED INFORMATIONDECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET MDxHealth Announces Completion of Transition to Single Listing on Nasdaq IRVINE, CA, and HERSTAL, BELGIUM – December 18, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announces the completion of its transition to a single listing on Nasdaq. In accordance with prior announcements made by the Company and the corporate event notice ...
MDxHealth annonce la réalisation de sa transition vers une cotation un...
MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE18 DECEMBRE 2023, 01:00 ET / 07:00 CET MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq IRVINE, CA, et HERSTAL, BELGIQUE - 18 decembre 2023 - MDxHealth SA (NASDAQ/Euronext Brussels : MDXH) (la " Société " ou " mdxhealth "), une société spécialisée dans le diagnostic de précision à un stade commercial, annonce aujourd'hui la réalisation de sa transition vers une cotation unique sur le Nasdaq. Conforméme...
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencem...
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq IRVINE, CA, and HERSTAL, BELGIUM – November 27, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announces the completion of the mandatory exchange under the Company's American ...
MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le ...
MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq IRVINE, CA, et HERSTAL, BELGIQUE - 27 novembre 2023 - MDxHealth SA (NASDAQ/Euronext Brussels : MDXH) (la " Société " ou " mdxhealth "), une société spécialisée dans le diagnostic de précision à un stade commercial, annonce au...
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare C...
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference NEWS RELEASENovember 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in a fireside chat at the 35th Piper Sandler Healthcare Conference on Wednesday, November 29, 2023, at 9:00am ET. A live webcast of th...
MDxHealth Announces Completion of Share Consolidation, and Update of O...
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights NEWS RELEASE - REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights IRVINE, CA, and HERSTAL, BELGIUM – November 13, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today announces that it completed the share consolidation with respect to all its outstanding shares b...
MDxHealth annonce la réalisation de son regroupement d'actions, et la ...
MDxHealth annonce la réalisation de son regroupement d'actions, et la mise à jour des actions et des droits de vote en circulation COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉEINFORMATION PRIVILÉGIÉE13 NOVEMBRE 2023, 16:00 ET / 22:00 CET MDxHealth annonce la réalisation de son regroupement d'actions, et la mise à jour des actions et des droits de vote en circulation IRVINE, CA, et HERSTAL, BELGIQUE - 13 novembre 2023 - MDxHealth SA (NASDAQ/Euronext : MDXH) ("mdxhealth" ou la "Société"), une société spécialisée dans le diagnostic de précision à un stade commercial, annonce aujourd'hui qu'...
- Hilde Van Boxstael
- Lynn Hautekeete
- Thibault Leneeuw
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Thomas Vranken
mdxhealth FIRST LOOK : 3Q23 Results Show Accelerating Growth
In line with its earlier announced 3Q23 highlights, mdxhealth's full 3Q23 results feature a continued strong uptake in revenues to $ 19.3m (+15% q/q), mainly driven by growth in Select mdx (+198% q/q) and Resolve mdx (+69% q/q). Furthermore, mdxhealth revealed a whopping 908 bp improvement in gross margins to 64.9% (KBCSe: 60.5%). Subsequently, cash burn reduced linearly as well, enabling visibility on adjusted EBITDA profitability in 1H25. Management indicated it expects to reach the high end o...
MDxHealth Reports Results for the Third Quarter and Nine-Month Period ...
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 NEWS RELEASE – REGULATED INFORMATION8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 IRVINE, CA, and HERSTAL, BELGIUM – November 8, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced its financial results for the third quarter and nine-month period ended September 30, 2023. Michael K. McGarrity, CEO of mdxhealth, commented: “We are please...
MDxHealth communique ses résultats pour le troisième trimestre et la p...
MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023 COMMUNIQUÉ DE PRESSE — INFORMATIONS RÉGLEMENTÉES8 NOVEMBRE 2023, 16 h 00 EDT/22 h 00 CET MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023 IRVINE, CA, et HERSTAL, BELGIQUE — le 8 novembre 2023 — MDxHealth SA (Euronext : MDXH), une société spécialisée dans le diagnostic de précision à un stade commercial a communiqué aujourd’hui ses résultats financiers pour le troisième trimestre et la pé...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Sharad Kumar S.P
- Thomas Vranken
- Wim Lewi
MDxHealth Announces the Approval by its Shareholders of the Proposed T...
MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation IRVINE, CA, and HERSTAL, BELGIUM – November 6, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostic...
MDxHealth annonce l'approbation par ses actionnaires de la proposition...
MDxHealth annonce l'approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d'actions COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉEINFORMATION PRIVILÉGIÉE6 NOVEMBRE 2023, 1:00 ET / 7:00 CET MDxHealth annonce l'approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d'actions IRVINE, CA, et HERSTAL, BELGIQUE - 6 novembre 2023 - MDxHealth SA (NASDAQ/Euronext Brussels : MDXH) (la "S...
MDxHealth to Present Third Quarter 2023 Financial Results and Corpora...
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 NEWS RELEASE25 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 Company to Host Conference Call with Live Q&A, November 8, 2023 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – October 25, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced it will release its financial results for the third quarter and nine-month period ended September 30, 2023, afte...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.